Navigation Links
Ventral Hernia Repair Market to Grow to Over $800 Million in 2013
Date:10/14/2008

High adoption of xenograft mesh to drive revenues, according to Millennium

Research Group

WALTHAM, Mass., Oct. 14 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Soft Tissue Repair 2009 report, the US market for ventral hernia repair is valued at almost $500 million and is expected to rise to over $825 million over the next five years. This market comprises both synthetic mesh and biologic mesh materials, which can be sourced from humans (allograft) or animals (xenograft). High adoption of xenograft mesh, coupled with growth in the US elderly and obese populations, will help drive the ventral hernia repair market over the next five years.

A hernia occurs when a tissue, structure, or part of an organ protrudes through an abnormal opening in the body; it is most commonly associated with the projection of the intestine through a weakness in the abdominal wall. Those hernias that develop at the site of a previous surgical incision are called ventral hernias, and are the second most common type of hernia. The condition frequently occurs in the abdominal wall where a previous incision weakened the abdominal muscles, resulting in a bulging of the area. Ventral hernias present a challenge because they occur in a variety of sizes, may be quite complicated to repair, and have relatively high recurrence rates.

"Xenograft mesh will experience rapid adoption for complex hernia repair over the next five years," says David Plow, Manager of MRG's General Medical Technology division. "This mesh has shown to be stronger, less expensive, more widely available, and safer with respect to disease transmission when compared to allograft products."

MRG's global coverage of the soft tissue repair device market also includes data on Europe. US Markets for Soft Tissue Repair 2009 provides coverage of key industry competitors, including C.R. Bard, Cook Medical, Covidien, Ethicon, LifeCell, W.L. Gore, and more.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net

Elizabeth Marshall

Decision Resources Inc.

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New Studies Find Plasma Disc Decompression Effective for Contained Disc Herniation
2. Stem cell regeneration repairs congenital heart defect
3. Neural Stem Cells May Help Repair Spina Bifida in Utero
4. Drug Given 24 Hours After Stroke Helps Repair Brain Tissue
5. Scripps research team unravels new cellular repair mechanism
6. New Skin Revitalizing Product Uses Naturally Occurring Serum for the Repair of Sun Damaged Skin
7. Spinal Cord Stem Cells May Act as Nerve Repair System
8. Faulty DNA repair could be a risk factor for lung cancer in nonsmokers
9. Evalve MitraClip: Clinical trial of nonsurgical repair for severe mitral valve regurgitation
10. 2nd Option Improves Abdominal Aorta Repair Outcomes
11. Joint distraction promotes structural repair in patients with severe knee osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... agile ecosystem and domain expertise for sponsors and CROs to speed clinical ... supply management (RTSM) software platform. Bioclinica AGILE RTSM provides seamless ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and funding ... randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients ... complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... 2017  Cardinal Health (NYSE: CAH ) ... earnings per share (EPS) guidance and providing a preliminary ... conjunction with this morning,s announcement of the planned acquisition ... Insufficiency businesses. Cardinal Health now believes that ... at the bottom of its previous guidance range of ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology: